Literature DB >> 15512878

Disease-modifying drug therapies.

Benjamin R Brooks, Mohammed Sanjak.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15512878     DOI： 10.1080/17434470410019898

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN： 1466-0822


× No keyword cloud information.
  6 in total

1.  Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery.

Authors:  Kate L Osman; Sabrina Kohlberg; Alexis Mok; Ryan Brooks; Lori A Lind; Katelyn McCormack; Andries Ferreira; Matan Kadosh; Mary K Fagan; Elizabeth Bearce; Nicole L Nichols; Joan R Coates; Teresa E Lever
Journal:  Dysphagia       Date:  2019-07-12       Impact factor: 3.438

2.  Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686].

Authors:  Benjamin Rix Brooks; Terry Heiman-Patterson; Martina Wiedau-Pazos; Shawn Liu; Jeffrey Zhang; Stephen Apple
Journal:  PLoS One       Date:  2022-06-14       Impact factor: 3.752

3.  Study of 962 patients indicates progressive muscular atrophy is a form of ALS.

Authors:  W-K Kim; X Liu; J Sandner; M Pasmantier; J Andrews; L P Rowland; H Mitsumoto
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

4.  Amyotrophic lateral sclerosis: one or multiple causes?

Authors:  Aline Furtado Bastos; Marco Orsini; Dionis Machado; Mariana Pimentel Mello; Sergio Nader; Júlio Guilherme Silva; Antonio M da Silva Catharino; Marcos R G de Freitas; Alessandra Pereira; Luciane Lacerda Pessoa; Flavio R Sztajnbok; Marco Araújo Leite; Osvaldo J M Nascimento; Victor Hugo Bastos
Journal:  Neurol Int       Date:  2011-04-29

Review 5.  Amyotrophic Lateral Sclerosis: New Perpectives and Update.

Authors:  Marco Orsini; Acary Bulle Oliveira; Osvaldo J M Nascimento; Carlos Henrique Melo Reis; Marco Antonio Araujo Leite; Jano Alves de Souza; Camila Pupe; Olivia Gameiro de Souza; Victor Hugo Bastos; Marcos R G de Freitas; Silmar Teixeira; Carlos Bruno; Eduardo Davidovich; Benny Smidt
Journal:  Neurol Int       Date:  2015-09-24

6.  Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym.

Authors:  Diane M Longo; Lisl K M Shoda; Brett A Howell; Vladimir Coric; Robert M Berman; Irfan A Qureshi
Journal:  Toxicol Sci       Date:  2020-06-01       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.